Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate for Alcohol Cue Reactivity in Alcohol Use Disorder
NCT07306078Phase 2Not yet recruiting
- Sponsor
- University of Florida
- Start
- Oct 2026
- Primary completion
- Aug 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of methylphenidate hydrochloride extended-release chewable tablet in alcohol use disorder (AUD), sponsored by University of Florida. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
methylphenidate hydrochloride extended-release chewable tablet
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT07306078.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07306078.